Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics
申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
公开号:US10400010B2
公开(公告)日:2019-09-03
This invention relates, e.g., to an inhibitory peptide or CPP inhibitor which specifically binds to p53 having an aberrant conformation (e.g., is aggregated or misfolded) and inhibits p53 amyloidogenic aggregation or restores proper folding of the misfolded protein. Methods of using the inhibitory peptide or CPP inhibitor (e.g. to treat subjects having tumors that comprise aggregated p53) are described.
本发明涉及一种抑制肽或CPP抑制剂,它能特异性地与具有异常构象(如聚集或错误折叠)的p53结合,并抑制p53的淀粉样聚集或恢复错误折叠蛋白的正常折叠。本文描述了使用抑制肽或 CPP 抑制剂(例如治疗具有包含聚集 p53 的肿瘤的受试者)的方法。